Clinical Trials Logo

Filter by:
NCT ID: NCT03625388 Not yet recruiting - Clinical trials for Chronic Myelogenous Leukemia

Low Dose Dasatinib (50 mg Daily) as First-line Treatment for Newly Diagnosed Chronic‐Phase Chronic Myeloid Leukemia

Start date: October 2018
Phase: Phase 2
Study type: Interventional

The purpose of this multicenter randomized study is to compare efficacy and safety of dasatinib 50 mg once daily and dasatinib 100 mg once daily in patients with early chronic phase (CP) chronic myeloid leukemia (CML)

NCT ID: NCT03571139 Recruiting - Clinical trials for Diabetic Retinopathy

Detecting the Influence of Cataract Surgery on the Development of Diabetic Retinopathy in Patients With Diabetes Mellitus Type 2 With and Without Diabetic Retinopathy Using OCT Angiography

Start date: June 1, 2018
Phase:
Study type: Observational

Detecting the influence of cataract surgery on the development of diabetic retinopathy in patients with diabetes mellitus type 2 with and without diabetic retinopathy using OCT angiography.

NCT ID: NCT03526315 Completed - Oral Health Clinical Trials

Antimicrobial Effect of Different Pastes on Streptococcus Mutans in Children

Start date: March 2016
Phase: N/A
Study type: Interventional

This study is a randomized controlled trial involving 127 children ages between 4 and 5 years to investigate the efficacy of Casein Phosphopeptide-Amorphous Calcium Phosphate (CPP-ACP) in reducing Streptococcus mutans (S. mutans) bacteria, and compare that with fluoride alone, or combined use of fluoride and CPP-ACP over a 6 month period using Saliva Check Mutans kits to detect Mutans Streptococci (MS). It is expected that all used anti-cariogenic agents will have the ability to reduce the S. mutans level in different values.

NCT ID: NCT03526276 Completed - Clinical trials for White Spot Lesion of Tooth

Effect of Different Pastes on Remineralization of Early Caries Lesions in Primary Teeth

Start date: March 2016
Phase: N/A
Study type: Interventional

This study is a randomized controlled trial involving 118 children ages between 4 and 5 years to assess the remineralization effect of Casein Phosphopeptide-Amorphous Calcium Phosphate (CPP-ACP) on white spot lesions in primary teeth using Quantitative Light-induced Fluorescence (QLF) system, and compare that with fluoride alone or combined use of fluoride and CPP-ACP.

NCT ID: NCT03522051 Active, not recruiting - Pulpotomy Clinical Trials

Assessment of Pulpotomy Procedure Using NeoMTA Plus in Permanent Teeth With Carious Exposure

PULPOTOMY
Start date: December 1, 2016
Phase: N/A
Study type: Interventional

Many deep carious teeth are treated unnecessarily by root canal therapy, while with using current techniques and advances in compatible dental materials in addition to better understanding of biological response of the dental pulp, many can be treated conservatively via vital pulp therapy procedures.

NCT ID: NCT03517982 Completed - Clinical trials for Acute Transplant Rejection in Patients Receiving Allogeneic Renal Transplant

Generic Mycophenolate Mofetil Safety Study for Prophylaxis in de Novo Renal Transplant Patients in Jordan

MyOra-PASS
Start date: October 2014
Phase:
Study type: Observational

The purpose of this observational study was to assess the safety and efficacy of generic mycophenolate mofetil in de novo renal transplant patients in Jordan where no visits or intervention(s) additional to the daily practice were performed.

NCT ID: NCT03507556 Recruiting - Revascularization Clinical Trials

Regeneration of Immature Teeth. Case Series

Start date: June 28, 2010
Phase: N/A
Study type: Interventional

This clinical study aims to investigate the predictability of revascularization procedure of immature necrotic human permanent teeth with apical periodontitis. The quality of root development (thickness and length) will be assessed radiographically.

NCT ID: NCT03503630 Not yet recruiting - Clinical trials for Locally Advanced Rectal Cancer

Short-course Radiation Followed by mFOLFOX-6 Plus COMPOUND 2055269 for Locally-advanced Rectal Adenocarcinoma

Start date: June 1, 2018
Phase: Phase 2
Study type: Interventional

The purpose of this study is to show that the addition of COMPOUND 2055269, an immunotherapeutic drug, to Folfox chemotherapy will improve the pathologic complete response rate in patients with locally advanced rectal cancer.

NCT ID: NCT03491722 Recruiting - Clinical trials for Risk Factors AND Repeat Revascularization

Surviving a Decade or More After Coronary Revascularization in a Middle Eastern Population

DECADE1+ME
Start date: June 1, 2018
Phase:
Study type: Observational

The study will look at the cardiovascular risk factors as they arise, as well at the need for further revascularization after at least 10 years of coronary revascularization in Middle Eastern patients

NCT ID: NCT03485742 Recruiting - Clinical trials for Myocardial Infarction

Statin Eligibility Prior to Myocardial InfarCtion

StatinEPIC
Start date: April 22, 2018
Phase:
Study type: Observational

The study (Statin Eligibility Prior to myocardial infarction (MI) in Jordanians, StatinEPIC) is 1. Cross sectional 2. Non interventional 3. One encounter per patient. No follow up. It addresses a major issue of primary prevention in Jordanians especially the young population, namely the issue of lipid lowering agents before sustaining an acute MI. A recent study in USA showed that 50% of patients who sustained MI were not eligible to statins had they been evaluated before the heart attack. It is largely unknown if a larger percentage of Middle Eastern patients who sustain a heart attack would be eligible to receive lipid lowering agents.